Advertisement

Topics

Emissary Capital Group, Inc. Company Profile

11:23 EDT 19th September 2017 | BioPortfolio

Emissary Capital Group, Inc. is a New York City-based company that provides strategic consulting and research services to emerging growth companies primarily based in India and China. The firm provides a diversified array of services to small and medium sized private companies, generally defined as those with annual revenues under $200 million, in order to assist them to become publicly traded companies in the U.S. For more information, please visit www.emissarycapital.com


News Articles [1276 Associated News Articles listed on BioPortfolio]

GL Capital-led consortium to buy SciClone Pharmaceuticals

A consortium featuring entities affiliated with GL Capital Management GP, Bank of China Group Investment (BOCGI), CDH Investments, Ascendent Capital Partners and Boying will acquire all the outstandin...

Baird Capital backs Prescient Healthcare Group

Group invests in the consultancy by dipping into its $310m fund

Heavily armed men storm hotel and a casino resort in Philippine capital

Gunfire was reported at a hotel and a casino resort in the Philippine capital on Friday, the operator of the complex said, and the Islamic State group (IS) quickly claimed responsibility. “Resorts ...

Series B round brings $55mm to Replimune

Replimune Group Inc. (oncolytic immunotherapies) raised $55mm through its Series B round. First-time investors Foresite Capital (lead and new board member), Bain Capital Life Sciences, Redmile Group, ...

M&As this week: Clinigen Group, Mekong Capital

Pharmaceuticals products provider Clinigen Group plans to acquire pharmaceutical company Quantum Pharma.

Monteris Medical secures $30mm Series B round

Monteris Medical Corp. (developing laser ablation systems for brain lesions as an alternative to craniotomy procedures) received commitments for a $30mm Series B round; the first tranche was received ...

Arsenal Capital Buys Cyalume for $45 million

New York-based private equity group Arsenal Capital Partners has signed a definitive agreement to acquire Cyalume Technologies Holdings for $45 million in cash.

Series B brings in $4mm for Carmell Therapeutics

Regenerative medicine firm Carmell Therapeutics Corp. raised $4mm in its Series B financing from returning shareholders Pittsburgh Life Sciences Greenhouse, Harbor Light Capital, Newlin Investments, a...

PubMed Articles [2779 Associated PubMed Articles listed on BioPortfolio]

Surgical Microanatomy of the Posterior Condylar Emissary Vein and its Anatomical Variations for the Transcondylar Fossa Approach.

It is essential to identify and be aware of the anatomy of the posterior condylar emissary vein (PCEV) for achieving an adequate operative field for the transcondylar fossa approach (TCFA).

A Tale of Two Towns: A Comparative Study Exploring the Possibilities and Pitfalls of Social Capital among People Seeking Recovery from Substance Misuse.

Social capital has become an influential concept in debating and understanding the modern world. Within the drug and alcohol sector, the concept of 'recovery capital' has gained traction with research...

Examination of the influence of social capital on depression in fragile families.

While it appears that social capital has a positive effect on mental health, most studies have been cross-sectional in nature and/or employ weak measures of social capital or mental health. Even less ...

Twenty years of social capital and health research: a glossary.

Research on social capital in public health is approaching its 20th anniversary. Over this period, there have been rich and productive debates on the definition, measurement and importance of social c...

Perceptions of community, social capital, and how they affect self-reported health: a multilevel analysis.

The link between social capital and self-reported health has been widely explored. On the other hand, we know less about the relationship between social capital, community socioeconomic characteristic...

Clinical Trials [3145 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Social Inequalities in Emergency Call and Emergency Response Patterns

Background: Inequality in access to healthcare is a challenge internationally. Despite that medical emergency calls can be considered as access point to pre-hospital emergency care and ...

Treatment of Sub-Capital Fractures of Hip Joint by Using TriboFit™ Acetabular Buffer

The purpose of this study is to determine the performance and efficacy during 6 and 12 month post operation. 1. determine changes in patient pain level 2. determine changes in ...

Study of Pregnancy Hormone Concentrations in Urban and Nomadic Mongolian Women

International variation in breast cancer rates and data from migrant and animal studies support the possibility that exposures early in development, including the in utero period, play a r...

Reducing the Rate and Duration of Re-ADMISsions Among Patients With Unipolar Disorder and Bipolar Disorder Using Smartphone-based Monitoring and Treatment - The RADMIS Trials

Unipolar and bipolar disorder combined account for nearly half of all morbidity and mortality due to mental and substance use disorders, and burden society with the highest health care cos...

Companies [2554 Associated Companies listed on BioPortfolio]

Emissary Capital Group, Inc.

Emissary Capital Group, Inc. is a New York City-based company that provides strategic consulting and research services to emerging growth companies primarily based in India and China. The firm provid...

Emissary LLC

Emissary manage and monitor clinical studies.

Emissary International LLC

Why Choose Emissary as Your Contract Research Organization?Emissary International has been navigating the clinical trials process for over a decade, earning itself a second-to-none reputation with cli...

Emissary Incorporated

Emissary Inc. is an international contract research organization (CRO) providing clinical research support to some of the top firms in the medical device, pharmaceutical, biotechnology and consumer he...

Human Capital Management Services Group

The Human Capital Management Services Group consists of three related companies that reduce healthcare costs, empower personal ownership of health decisions, measurably grow productivity and business ...

More Information about "Emissary Capital Group, Inc." on BioPortfolio

We have published hundreds of Emissary Capital Group, Inc. news stories on BioPortfolio along with dozens of Emissary Capital Group, Inc. Clinical Trials and PubMed Articles about Emissary Capital Group, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Emissary Capital Group, Inc. Companies in our database. You can also find out about relevant Emissary Capital Group, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...


Corporate Database Quicklinks



Searches Linking to this Company Record